Xueyou Ma

1.1k total citations
29 papers, 687 citations indexed

About

Xueyou Ma is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xueyou Ma has authored 29 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xueyou Ma's work include Epigenetics and DNA Methylation (10 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (9 papers). Xueyou Ma is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (9 papers). Xueyou Ma collaborates with scholars based in China, United States and Finland. Xueyou Ma's co-authors include Yufan Ying, Jiangfeng Li, Xiangyi Zheng, Liping Xie, Haiyun Xie, Zhihua Wang, Chunguang Yang, Ben Liu, Xiao Wang and Liujia He and has published in prestigious journals such as Cancer Letters, Cell Death and Disease and Oncotarget.

In The Last Decade

Xueyou Ma

26 papers receiving 683 citations

Peers

Xueyou Ma
Junjie Cen China
Ren Jie Jin United States
Juanjie Bo China
Yufan Ying China
Fengzhou Li China
Shuier Zheng China
Junjie Cen China
Xueyou Ma
Citations per year, relative to Xueyou Ma Xueyou Ma (= 1×) peers Junjie Cen

Countries citing papers authored by Xueyou Ma

Since Specialization
Citations

This map shows the geographic impact of Xueyou Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyou Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyou Ma more than expected).

Fields of papers citing papers by Xueyou Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueyou Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyou Ma. The network helps show where Xueyou Ma may publish in the future.

Co-authorship network of co-authors of Xueyou Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xueyou Ma. A scholar is included among the top collaborators of Xueyou Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueyou Ma. Xueyou Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Dingheng, Yuxiao Li, Yuchen Shi, et al.. (2025). miR-9-5p/HMMR regulates the tumorigenesis and progression of clear cell renal cell carcinoma through EMT and JAK1/STAT1 signaling pathway. Journal of Translational Medicine. 23(1). 36–36. 4 indexed citations
2.
3.
Ying, Yufan, Xueyou Ma, Yuqing Wu, et al.. (2025). SREBF1-mediated SND1 transcriptional activation promotes prostate cancer progression via MTDH interaction through the SESN2/AMPK/mTOR axis. Journal of Translational Medicine. 23(1). 885–885.
4.
Wu, Yuqing, Yufan Ying, Fenghao Zhang, et al.. (2024). NSUN2-mediated R-loop stabilization as a key driver of bladder cancer progression and cisplatin sensitivity. Cancer Letters. 611. 217416–217416. 4 indexed citations
5.
Shu, Xuan, Jiaming Wang, Wen Cai, et al.. (2024). Clinical assessment of urinary prostate cancer antigen 3 in Chinese population: a large-scale, prospective and multicenter study. World Journal of Surgical Oncology. 22(1). 355–355.
6.
Shu, Xuan, Jiangfeng Li, Yufan Ying, et al.. (2024). N6-methyladenosine-modified circRPS6KC1 regulated cellular senescence in prostate cancer via FOXM1/PCNA axis. Cellular Signalling. 125. 111510–111510. 8 indexed citations
7.
Ma, Xueyou, Yufan Ying, Xuan Shu, et al.. (2024). N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128–3p/MAPK1 axis. Cancer Letters. 585. 216613–216613. 14 indexed citations
8.
Shen, Haixiang, Yufan Ying, Xueyou Ma, et al.. (2022). FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m6A dependent pathway. Cell Death Discovery. 8(1). 356–356. 14 indexed citations
9.
Ma, Xueyou, Qin Zhang, Kaifang Ma, et al.. (2022). VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells. Cell & Bioscience. 12(1). 52–52. 5 indexed citations
10.
Ma, Xueyou, Yufan Ying, Weiyu Wang, et al.. (2022). SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration and proliferation in bladder cancer. Cell Death Discovery. 8(1). 199–199. 13 indexed citations
11.
Ying, Yufan, Xueyou Ma, Weiyu Wang, et al.. (2021). EGR2-mediated regulation of m6A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization. Cell Death and Disease. 12(8). 750–750. 62 indexed citations
12.
Wang, Song, Xueyou Ma, Yufan Ying, et al.. (2021). Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma. Cancer Cell International. 21(1). 341–341. 21 indexed citations
13.
Ma, Xueyou, et al.. (2021). Effects of fluorescent light cystoscopy in non-muscle-invasive bladder cancer: A systematic review and meta-analysis. Photodiagnosis and Photodynamic Therapy. 34. 102248–102248. 4 indexed citations
14.
Ma, Xueyou, Yufan Ying, Haiyun Xie, et al.. (2021). circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis. Cell Death Discovery. 7(1). 365–365. 20 indexed citations
15.
Ma, Xueyou, Yufan Ying, Haiyun Xie, et al.. (2021). The Regulatory Role of RNA Metabolism Regulator TDP-43 in Human Cancer. Frontiers in Oncology. 11. 755096–755096. 19 indexed citations
16.
He, Liujia, Yufan Ying, Haiyun Xie, et al.. (2021). MicroRNA‐501‐3p inhibits the proliferation of kidney cancer cells by targeting WTAP. Cancer Medicine. 10(20). 7222–7232. 24 indexed citations
17.
Xie, Haiyun, Jiangfeng Li, Yufan Ying, et al.. (2020). METTL3/YTHDF2 m 6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer. Journal of Cellular and Molecular Medicine. 24(7). 4092–4104. 114 indexed citations
18.
Xiao, Jun, Meng Wang, Wei He, et al.. (2019). Does Postoperative Rehabilitation for Radical Cystectomy Call for Enhanced Recovery after Surgery? A Systematic Review and Meta-analysis. Current Medical Science. 39(1). 99–110. 15 indexed citations
19.
Yang, Chunguang, Xueyou Ma, Zhihua Wang, et al.. (2017). Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation. Drug Design Development and Therapy. Volume11. 431–439. 84 indexed citations
20.
Ma, Xueyou, Kun Tang, Chunguang Yang, et al.. (2016). Bladder neck preservation improves time to continence after radical prostatectomy: a systematic review and meta-analysis. Oncotarget. 7(41). 67463–67475. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junjie Cen Breakdown of academic impact, for papers by Ren Jie Jin Breakdown of academic impact, for papers by Juanjie Bo Breakdown of academic impact, for papers by Yufan Ying Breakdown of academic impact, for papers by Fengzhou Li Breakdown of academic impact, for papers by Shuier Zheng
Rankless by CCL
2026